Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
BioAge Labs, Inc. (NASDAQ: BIOA)
BIOA Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-96.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
193.40%
BIOA Stock Analysis
BIOA
PE Ratio:
BIOA
PEG Ratio:
Not Available
BIOA
Forward EPS Growth (12 month):
0.00%
BIOA
PS Ratio:
58.5
BIOA
PSG Ratio:
-0.6
BIOA
Forward Revenue Growth (12 month):
-94.00%
BIOA Articles
No data was found